HIF-PHIs and ESAs Have Comparable Adverse Effects : vimarsan

Investigators compared the safety and adverse effects of HIF-PHIs and ESAs for treating anemia in CKD.

Related Keywords

China , Beijing , Dongzhimen , United States , American , Wei Jing Liu , University Of Chinese Medicine , American Journal , Kidney Diseases , Dongzhimen Hospital , Beijing University , Chinese Medicine ,